ABT

Abbott Laboratories

105.68 USD
-0.04 (-0.04%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

Abbott Laboratories stock is up 1.39% since 30 days ago. The dividend yield is 2.13% and its next earnings date is Jul 18, 2024. The company has had above-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 58% of the previous 49 June’s closed higher than May. In the last 10 Unusual Options Trades, there were 8 CALLs, 2 PUTs. 100% of analysts rate it a buy.

Options Flow Last 10
Date & Time Expiration Date Strike Price Trade Type Size Open Interest
20 Jun 15:31 16 Aug, 2024 100.00 CALL 100 1222
20 Jun 15:35 16 Aug, 2024 105.00 CALL 247 1019
20 Jun 16:30 17 Jan, 2025 110.00 CALL 57 3241
21 Jun 16:00 20 Jun, 2025 80.00 CALL 10 27
21 Jun 16:43 20 Sep, 2024 110.00 CALL 98 986
21 Jun 16:57 19 Jul, 2024 105.00 PUT 2000 1542
21 Jun 18:42 19 Jul, 2024 105.00 PUT 160 1542
21 Jun 18:55 21 Jun, 2024 104.00 CALL 192 1245
21 Jun 19:52 17 Jan, 2025 100.00 CALL 39 1878
21 Jun 19:54 17 Jan, 2025 100.00 CALL 47 1878

About Abbott Laboratories

Abbott Laboratories discovers, develops, manufactures, and sells health care products. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Medical Devices segment offers rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular diseases.

  • RBC Capital
    Tue Jun 4, 09:34
    buy
    confirm
  • Goldman Sachs
    Thu May 30, 07:37
    buy
    initial